TREMIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tremin, and what generic alternatives are available?
Tremin is a drug marketed by Schering and is included in one NDA.
The generic ingredient in TREMIN is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tremin
A generic version of TREMIN was approved as trihexyphenidyl hydrochloride by WATSON LABS on December 31st, 1969.
Summary for TREMIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Patent Applications: | 1,912 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TREMIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TREMIN
US Patents and Regulatory Information for TREMIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | TREMIN | trihexyphenidyl hydrochloride | TABLET;ORAL | 080381-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | TREMIN | trihexyphenidyl hydrochloride | TABLET;ORAL | 080381-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |